Blake Wise, Novome CEO
November 10, 2021 09:25 AM ESTUpdated November 12, 09:23 PM
Deals

Genen­tech teams with lit­tle Novome on IBD re­search, look­ing to col­o­nized bac­te­ria af­ter a se­vere set­back

John Carroll

Editor & Founder

Back at the be­gin­ning of 2020, Genen­tech vet Blake Wise jumped to a start­up in the Bay Area called Novome, join­ing at the same time …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Viking's oral weight loss drug ap­pears to have strong ef­fect in Phase 1 tri­al

Is there room for MASH drugs in a GLP-1 world?

'We play to win': As­traZeneca de­tails first re­sults for oral GLP-1 and broad­er obe­si­ty am­bi­tions

No­vo adds to We­govy’s car­dio strength with hos­pi­tal ad­mis­sions analy­sis

Cin­Rx touts pos­i­tive ear­ly-stage da­ta from two obe­si­ty can­di­dates

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times